Anti-Ferritin Heavy Chain antibody [EPR3005Y] (ab75972)

Publishing research using ab75972? Please let us know so that we can cite the reference in this datasheet.

ab75972 has been referenced in 6 publications.

  • Vannucci L  et al. In Vivo Targeting of Cutaneous Melanoma Using an Melanoma Stimulating Hormone-Engineered Human Protein Cage with Fluorophore and Magnetic Resonance Imaging Tracers. J Biomed Nanotechnol 11:81-92 (2015). IHC-P ; Human . PubMed: 26301302
  • Yang H  et al. Upregulation of mitochondrial ferritin by proinflammatory cytokines: implications for a role in Alzheimer's disease. J Alzheimers Dis 45:797-811 (2015). PubMed: 25624418
  • Maxwell P  et al. Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation. Br J Haematol 168:429-42 (2015). PubMed: 25283956
  • Ariza J  et al. Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome. Brain Res 1598:88-96 (2015). IHC-Fr ; Human . PubMed: 25498860
  • Liu NQ  et al. Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response. Mol Cell Proteomics 13:1814-27 (2014). IHC ; Human . PubMed: 24742827
  • Lanceta L  et al. Heme oxygenase-1 overexpression alters intracellular iron distribution. Biochem J : (2012). PubMed: 22989377

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"